Stevanato Group S.p.A. Profile Avatar - Palmy Investing

Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, …
Medical - Instruments & Supplies
IT, Piombino Dese [HQ]
STVN/Financial Reporting

Income Statements

5 Sheets · Starting from 2023
In Million EUR. Margins, Growth Rates In %
Metric 2019 2020 2021 2022 2023
Revenue
536.00 662.00 843.00 983.00 1,063.00
EPS
0.15 0.28 0.53 0.53 0.54
Profit
138.00 194.00 265.00 319.00 319.00
Pre Tax
54.00 96.00 165.00 187.00 185.00
ETR
29.26 18.37 18.95 23.77 23.14
Net
39.00 78.00 134.00 142.00 145.00
EBITDA
108.00 157.00 184.00 217.00 263.00
Operating Income
62.00 103.00 128.00 152.00 186.00
Interest Income
- - - - 21.00 25.00 - -
Loss
-474.00 -558.00 -681.00 -791.00 -876.00
Cost of Revenue
-398.00 -467.00 -578.00 -663.00 -743.00
Operating Expenses
-75.00 -91.00 -103.00 -127.00 -133.00
Depreciation and Amortization
-46.00 -54.00 -56.00 -64.00 -76.00
Interest Expenses
-5.00 -5.00 -18.00 -29.00 -4.00
Other Expenses
-7.00 -6.00 -37.00 -35.00 - -
WA Shares Outstanding
264.00 264.00 264.00 264.00 264.00
End of STVN's Analysis
CIK: 1849853 CUSIP: T9224W109 ISIN: IT0005452658 LEI: - UEI: -
Secondary Listings
STVN has no secondary listings inside our databases.